Navigation Links
Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
Date:3/3/2008

MONTVALE, N.J., March 3 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that the U.S. District Court for the District of New Jersey has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Bayer Schering Pharma, AG in connection with Bayer Schering's Yasmin(R) (drospirenone and ethinyl estradiol) oral contraceptive. In his ruling, Judge Peter G. Sheridan found that the patent at issue was invalid, because it was obvious.

"We are delighted that Judge Sheridan has invalidated the patent on Yasmin," said Bruce L. Downey, Barr's Chairman and CEO. "We are currently reviewing the opinion in the case and evaluating all of our options. Clearly, this is a positive development for the Company and we are evaluating what the potential impact could be on our earnings guidance for 2008."

Yasmin provides an oral contraceptive regimen consisting of 21 active tablets each containing 3 mg of drospirenone and 0.03 mg of ethinyl estradiol and 7 inert tablets. Yasmin is indicated for the prevention of pregnancy in women who elect to use an oral contraceptive. The product had annual sales of approximately $572 million for the twelve months ended December 2007, based on IMS sales data.

Barr filed its Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for a generic Yasmin product with the U.S. Food & Drug Administration (FDA) in January 2005, and received notification of the application's acceptance for filing in February 2005. Following receipt of the notice from the FDA, Barr notified Berlex, the New Drug Application (NDA) holder, and Schering AG, the patent owner. In April 2005, Schering AG and Berlex filed a patent infringement sui
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...Newswire/ -- TechConnect World, an event bringing ... product integration in cleantech, nanotech, biote...for technology abstracts and business presentation...in association with the Nano Science and Technolog...ustainable Industries Organization (CTSI), will br...
(Date:12/2/2009)...e/ -- S*BIO Pte Ltd today announced data presentat...The American Society of Hematology 51st Annual Mee...l be presented on the clinical results from the Ph...s safety, tolerability and pharmacokinetic/pharmac...om 100 to 600 mg. These doses were administered on...
(Date:12/2/2009)...ewswire-Asia/ -- Simcere Pharmaceutical Group,("Si... pharmaceutical company,specializing in the develo...eric and proprietary pharmaceuticals in China, tod...ded in China,s National Drug Reimbursement List,("...man Resources and Social,Security on November 30, ...
(Date:12/2/2009)...e-Asia/ -- The world is going through,extraordinar... part of many,businesses and industries. It turns ...mmune to the economic downturn, because illness do... of the difficult times this year, the pharmaceuti...mp;D center in Shanghai, the largest of,its kind i...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
... there are many companies trying to aggressively u...es have ranged from total site revamps to well tho... , ,I thought it would be interesting to review so...d their perceived impact. , , Case 1: Dell , ,Wi...sively trying to rebuild its customer reputation a...
..., Saint Luke,s Health System of Kansas City, will ...care Conference May 9 and 10 in Madison. He recen...ffered a candid assessment of the state of health ...y remaining barriers to wider adoption of electron... there are a couple. First, there is the cost of i...
...ent Bush severely out of touch, Wisconsin Gov. Ji... for passage of a bill to lift federal restriction...legislation, Senate Bill 5 - the Stem Cell Researc...e Senate. It would end restrictions on additional ...urged passage of the bill in a letter to senator...
Other Biology Technology:On the case: Web lessons for connecting with customers 2On the case: Web lessons for connecting with customers 3On the case: Web lessons for connecting with customers 4On the case: Web lessons for connecting with customers 5Visions: Wade offers straight talk on e-medical records 2Visions: Wade offers straight talk on e-medical records 3Visions: Wade offers straight talk on e-medical records 4Visions: Wade offers straight talk on e-medical records 5Doyle joins governors in support of stem cell bill 2
(Date:12/1/2009)...s have two different feeding strategies. A large ...ng that they are generalist predators feeding on o... Some, however, are "herbivorous". This is not t...of their diets consist of plant-derived matter. Fo...y plants to attract ants, called extra-floral nect...
(Date:12/1/2009)...iNose is pleased to announce the publication of re...ng the efficacy and tolerability of its novel, int...ent of chronic rhinosinusitis with nasal polyps in...ional and European Rhinologic Societies. , Chro...disease that can significantly reduce a patient,s ...
(Date:12/1/2009)...imer,s disease, nerve cell degeneration plays a cr... may possibly be derived from steering the generat...e been published in the current issue of the renow...w years ago, neurogenesis the process of nerve ce... the adult brain. The textbooks asserted that dead...
Breaking Biology News(10 mins):Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2New source discovered for the generation of nerve cells in the brain 2Intensive Dialysis Doesnt Save Lives of the Sickest 59940 1Intensive Dialysis Doesnt Save Lives of the Sickest 59940 2Intensive Dialysis Doesnt Save Lives of the Sickest 59940 3Sex of Twins May Affect Outcomes 59938 1Sex of Twins May Affect Outcomes 59938 2Sex of Twins May Affect Outcomes 59938 3Pitt NIH team find way to protect healthy cells from radiation damage 59936 1Pitt NIH team find way to protect healthy cells from radiation damage 59936 2
...ing skimmed milk could soon be roaming our pasture...stry, the magazine of the SCI. Scientists in New ...that give them a natural ability to produce skimme...erds of milkers producing only skimmed milk. , Th...producing milk with the unique characteristics req...
...vered from the potentially deadly H5N1 strain of a...ts for the virus, according to an international te...he open access journal PLoS Medicine, the research...avian flu survivors in Vietnam can be reproduced i...ng the virus in culture vitro and in mice. , The H...
...have a keen sense of smell, which in many species ...o new research from Boston University marine biolo...te prey; they also need their skin – specifically ...ne is an organ used by all fish to detect, with ex... surrounding water. According to the research team...
Other Biology News:Skimmed milk -- Straight from the cow 2Avian influenza survivors' antibodies effective at neutralising H5N1 strain 2New research shows sharks use their noses and bodies to locate smells 2New research shows sharks use their noses and bodies to locate smells 3
Recorder REC-111 single-channel from GE Healthcare, formerly Amersham Biosciences
...or when you need to make your strain of cells comp...cy. Our services for preparing competent cells are...tions. MCLab's custom competent cell service offer...Fast turnaround Quality control performance test...
MEK1, total EIA Kit from Assay Designs/Stressgen Bioreagents
Argon Calibration Source from Ocean Optics
Biology Products: